Lydia Usha
Impact in
-
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
-
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Co-authors
- Melody Cobleigh (12 shared papers)Ruta Rao (7 shared papers)Akansha Chowdhary (2 shared papers)Kirtesh R. Patel (2 shared papers)Dian Wang (2 shared papers)Neilayan Sen (2 shared papers)Parul Barry (3 shared papers)Mudit Chowdhary (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of the National Comprehensive Cancer Network (2 papers)Cancer Research (2 papers)The Oncologist (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Lydia Usha
34 papers receiving 290 citations
Peers
Comparison fields: 5 of 60
- Oncology 150
- Cancer Research 82
- Reproductive Medicine 34
- Pathology and Forensic Medicine 44
- Pulmonary and Respiratory Medicine 68
Countries citing papers authored by Lydia Usha
This map shows the geographic impact of Lydia Usha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Usha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Usha more than expected).
Fields of papers citing papers by Lydia Usha
This network shows the impact of papers produced by Lydia Usha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Usha. The network helps show where Lydia Usha may publish in the future.
Co-authors
The 25 scholars most cited alongside Lydia Usha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 49 | |
| 2 | 2011 | 46 | |
| 3 | 2014 | 28 | |
| 4 | 2012 | 22 | |
| 5 | 2018 | 19 | |
| 6 | 2007 | 19 | |
| 7 | 2013 | 13 | |
| 8 | 2021 | 11 | |
| 9 | 2017 | 11 | |
| 10 | 2015 | 8 | |
| 11 | 2019 | 7 | |
| 12 | 2017 | 6 | |
| 13 | 2008 | 5 | |
| 14 | 2014 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2016 | 4 | |
| 18 | Hereditary inflammatory breast cancer associated with BRCA2 mutation: a rare disease presentation in mother and daughter. | 2012 | 4 |
| 19 | 2021 | 3 | |
| 20 | 2013 | 3 |
About Lydia Usha
Lydia Usha is a scholar working on Oncology, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 39 papers that have together received 296 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (11 papers), PARP inhibition in cancer therapy (10 papers), Cancer Genomics and Diagnostics (7 papers), Breast Cancer Treatment Studies (5 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Oncology (150 citations), Cancer Research (82 citations), Reproductive Medicine (34 citations), Pathology and Forensic Medicine (44 citations) and Pulmonary and Respiratory Medicine (68 citations). Lydia Usha has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Melody Cobleigh, Ruta Rao, Akansha Chowdhary, Kirtesh R. Patel, Dian Wang, Neilayan Sen, Parul Barry, Mudit Chowdhary, Lela Buckingham and Xiulong Xu. Their work appears in journals such as Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network, Cancer Research, The Oncologist and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.